 | Up a level |
Li, Bojun; Heldner, Mirjam R.; Arnold, Marcel; Coutinho, Jonathan M; Zuurbier, Susanna M; Meijers, Joost C M; Kohler, Hans P; Schroeder, Verena (2019). Coagulation Factor XIII in Cerebral Venous Thrombosis. TH open, 3(3), e227-e229. Thieme 10.1055/s-0039-1693487
Schroeder, Verena; Kohler, Hans P (2016). Factor XIII: Structure and Function. Seminars in thrombosis and hemostasis, 42(4), pp. 422-428. Thieme Medical Publishers 10.1055/s-0036-1571341
Schroeder, Verena; Ortner, Elisabeth; Mono, Marie-Luise; Galimanis, Aekaterini; Meier, Niklaus; Findling, Oliver; Fischer, Urs; Brekenfeld, Caspar; Arnold, Marcel; Mattle, Heinrich P; Kohler, Hans P (2010). Coagulation factor XIII activation peptide and subunit levels in patients with acute ischaemic stroke: a pilot study. Thrombosis research, 126(2), e122-e127. Amsterdam: Elsevier 10.1016/j.thromres.2010.05.027
Schroeder, Verena; Kohler, Hans P (2010). Thrombelastographic studies on factor XIII. Thrombosis and haemostasis, 104(6), pp. 1277-1279. Stuttgart: Schattauer 10.1160/TH10-06-0372
Ortner, Elisabeth; Schroeder, Verena; Walser, Reto; Zerbe, Oliver; Kohler, Hans P (2010). Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events. Blood, 115(24), pp. 5089-5096. Washington, D.C.: American Society of Hematology 10.1182/blood-2009-11-253062
Schroeder, Verena; Borner, Urs; Gutknecht, Stefan; Schmid, Jean-Paul; Saner, Hugo; Kohler, Hans P (2007). Relation of depression to various markers of coagulation and fibrinolysis in patients with and without coronary artery disease. European journal of cardiovascular prevention & rehabilitation, 14(6), pp. 782-787. Los Angeles, Calif.: Sage 10.1097/HJR.0b013e32828622e8
Schroeder, Verena; Vuissoz, Jean-Marc; Caflisch, Amedeo; Kohler, Hans P (2007). Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form. Thrombosis and haemostasis, 97(6), pp. 890-898. Stuttgart: Schattauer 10.1160/TH06-08-0458
Schroeder, Verena; Meili, Esther; Cung, Trinh; Schmutz, Peter; Kohler, Hans P (2006). Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thrombosis and haemostasis, 95(1), pp. 77-84. Stuttgart: Schattauer 10.1160/TH05-06-0388
Schroeder, Verena; Wilmer, Marianne; Buehler, Beatrice; Kohler, Hans P (2006). TAFI activity in coronary artery disease: a contribution to the current discussion on TAFI assays. Thrombosis and haemostasis, 96(2), pp. 236-237. Stuttgart: Schattauer 10.1106/TH06-06-0295
Kucher, Nils; Schroeder, Verena; Kohler, Hans P (2003). Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness. Thrombosis and haemostasis, 90(3), pp. 434-438. Schattauer 10.1160/TH03-07-0031
Schroeder, Verena; Kohler, Hans P (2003). Factor XIII activation by thrombin depends on FXIIIVal34Leu genotype. Blood, 101(1), pp. 371-372. American Society of Hematology 10.1182/blood-2002-08-2427
Schroeder, Verena; Chatterjee, Tushar; Mehta, Haresh; Windecker, Stephan; Pham, Trinh; Devantay, Nicolas; Meier, Bernhard; Kohler, Hans P (2002). Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thrombosis and haemostasis, 88(6), pp. 1020-1025. Schattauer
Ferrari, Paolo; Schroeder, Verena; Anderson, Suzanne; Kocovic, Leonardo; Vogt, Bruno; Schiesser, Daniela; Marti, Hans-Peter; Ganz, Reinhold; Frey, Felix J; Kohler, Hans P (2002). Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation, 74(8), pp. 1147-1152. Lippincott Williams & Wilkins 10.1097/01.TP.0000035848.73883.1B
